跳至主要内容
临床试验/NCT06906770
NCT06906770已完成不适用

Virtual Reality-based Eye Movement Desensitisation and Reprocessing Therapy for Specific Phobias

The University of Northampton2 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2025年4月28日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
17
试验地点
2
主要终点
Change in Subjective Units of Distress (SUDs)

研究概览

简要总结

The goal of this clinical trial is to study the effectiveness of a virtual reality-based eye movement desensitization and reprocessing (EMDR) application in treating phobia. It will also learn about the feasibility and safety of the application for independent use.

The main questions it aims to answer are:

Does the VR EMDR application reduce distress, improve positive cognitions, and decrease avoidance of specific phobias? Can the application help diminish phobia-related bodily sensations and encourage cognitive shifts toward positive beliefs and greater confidence in confronting previously avoided situations? Can the participants independently administer the treatment with minimum assistance?

Participants will:

Visit the site and take the VR EMDR phobia treatment every day for one week. Report their phobia and simulator sickness symptoms through self-report questionnaires or semi-structured interviews.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
17 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have a specific phobia (not necessarily clinically significant)

排除标准

  • Diagnosis of mental health disorders
  • History of trauma associated with their phobia
  • History of panic attacks associated with their phobia
  • History of psychosis
  • Current self-harm
  • Current suicidal ideation
  • Regular use of substances that might affect mental state
  • Regular use of medications that might affect mental state
  • Significant visual impairments
  • Severe motion sickness

结局指标

主要结局

Change in Subjective Units of Distress (SUDs)

时间窗: Recorded 4 times during each VR EMDR session (first being baseline, and the subsequent three were recorded after each eye movement set in desensitisation phrase) across the 5 consecutive intervention days.

The Subjective Units of Distress Scale (SUDs) is a self-reported measure of distress experienced by participants during each virtual reality (VR) EMDR session. Participants will rate their level of distress on a scale from 0 (no distress) to 10 (highest distress). Outcome is measured by the change in SUD score throughout each session and cumulative change from Day 1 to Day 5.

Change in Validity of Cognitions (VoC)

时间窗: Recorded 4 times during each VR EMDR session (first being baseline, and the subsequent three were recorded after each eye movement set in installation phrase) across the 5 consecutive intervention days.

The Validity of Cognition (VoC) scale measures the strength of positive cognitions related to the phobic trigger. Participants will rate how true their preferred positive cognition feels on a scale from 1 (completely false) to 7 (completely true) during each VR EMDR session. Outcome is measured by change in VoC score throughout each session and cumulative change from Day 1 to Day 5.

Change in IAPT Phobia Scale Score

时间窗: Baseline (Day 0, pre-intervention) and post-intervention (Day 5).

The Improving Access to Psychological Therapies (IAPT) Phobia Scale assesses the severity of phobic symptoms in terms of avoidance behaviour. Participants will complete the scale before the intervention (baseline) and immediately after the final session (Day 5). Outcome is measured by the change in IAPT Phobia Scale score from baseline to Day 5 post-intervention. Participants achieved remission if they scored below the threshold of 4 in the Improving Access to Psychological Therapies Phobia (IAPT) phobia scale.

The Severity Measure for Specific Phobia-Adult

时间窗: Baseline (Day 0, pre-intervention) and post-intervention (Day 5).

The Severity Measure for Specific Phobia-Adult is a 10-item measure that assesses the severity of specific phobia in individuals age 18 and older. The measure was designed to be completed by an individual upon receiving a diagnosis of specific phobia (or clinically significant specific phobia symptoms) and thereafter, prior to follow-up visits with the clinician. Each item asks the individual to rate the severity of his or her specific phobia during the past 7 days.

次要结局

  • Simulator Sickness Questionnaire (SSQ) Score Change(Day 1 and Day 5 post-intervention.)
  • Participant Adherence(Day 5 post-intervention.)
  • Participant Acceptability(Day 5 post-intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Virtual Reality-based Eye Movement Desensitisation... | 临床试验